MedPath

Aneurysmal Subarachnoid Hemorrhage: Red Blood Cell Transfusion and Outcome

Phase 2
Completed
Conditions
Subarachnoid Hemorrhage
Interventions
Other: Liberal Red Blood Cell Transfusion Strategy
Other: Restrictive Red Blood Cell Transfusion Strategy
Registration Number
NCT02483351
Lead Sponsor
Ottawa Hospital Research Institute
Brief Summary

The purpose of this study is to determine the feasibility of conducting a large trial examining the effect on clinical outcome of a liberal red blood cell (RBC) transfusion strategy compared to a restrictive strategy (usual care) in patients with aneurysmal subarachnoid hemorrhage (SAH).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Age ≥18 years old at time of presentation
  2. First ever episode aneurysmal SAH
  3. Confirmed aneurysmal SAH diagnosis: as confirmed by treating Neurosurgeon or Neuro-interventionalist and supported by blood in subarachnoid space (demonstrated on cranial imaging or cerebrospinal fluid positive for xanthochromia) that is the result of a ruptured saccular aneurysm (confirmed by cranial imaging - cranial topography or magnetic resonance imaging angiography or catheter angiogram)
  4. Incident hemoglobin ≤100g/L within 14 days following SAH (defined by first day of hospital presentation)
Read More
Exclusion Criteria
  1. Physician and or family decision to withdraw/withhold critical care at time of enrolment
  2. Active bleeding with hemodynamic instability at time of enrolment
  3. Patients with contra-indication or known objection to blood transfusions
  4. SAH due to causes other than saccular aneurysm rupture including mycotic, traumatic and dissecting aneurysms, and aneurysms associated with arteriovenous malformations.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Liberal RBC Transfusion StrategyLiberal Red Blood Cell Transfusion Strategy-
Restrictive RBC Transfusion StrategyRestrictive Red Blood Cell Transfusion Strategy-
Primary Outcome Measures
NameTimeMethod
Randomization Rate12 months
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (3)

Vancouver General Hospital

🇨🇦

Vancouver, British Columbia, Canada

Hamilton Health Sciences Centre

🇨🇦

Hamilton, Ontario, Canada

Shane English

🇨🇦

Ottawa, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath